Next Article in Journal
Semen Quality in Rams Is Severely but Temporarily Affected by Bluetongue Virus Serotype 3 Infection
Previous Article in Journal
Cellular eEF1G Inhibits Porcine Deltacoronavirus Replication by Binding Nsp12 and Disrupting Its Interaction with Viral Genomic RNA
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Genetic Characterization and Pathogenesis of Highly Pathogenic Avian Influenza Virus A (H5N1) Isolated in Egypt During 2021–2023

1
Center of Scientific Excellence for Influenza Viruses, National Research Centre, Giza 12622, Egypt
2
Department of Biotechnology, Faculty of Science, Cairo University, Cairo 12613, Egypt
3
Department of Anatomy and Embryology, Faculty of Medicine, Cairo University, Cairo 12613, Egypt
4
Department of Botany and Microbiology, Faculty of Science, Cairo University, Giza 12613, Egypt
5
Department of Infectious Diseases, St. Jude Children’s Research Hospital, Memphis, TN 38105, USA
6
Human Link DMCC, Dubai P.O. Box 48800, United Arab Emirates
*
Authors to whom correspondence should be addressed.
Viruses 2025, 17(10), 1370; https://doi.org/10.3390/v17101370
Submission received: 12 September 2025 / Revised: 9 October 2025 / Accepted: 10 October 2025 / Published: 13 October 2025
(This article belongs to the Section General Virology)

Abstract

Highly pathogenic avian influenza (HPAI) viruses have recently had a substantial impact on global poultry production and public health. In Egypt, clade 2.3.4.4b HPAI H5N1 viruses were first isolated from wild birds in 2021 and then became dominant in domestic poultry. In this study, we aimed to genetically characterize the H5N1 viruses isolated in Egypt during 2021–2023 and examine the pathogenicity and transmissibility of two H5N1 strains isolated from wild and domestic poultry in chickens. We collected 7588 specimens from live bird markets including poultry, wild birds, and environmental samples. Influenza A viruses were detected in 20.94% (484/2311) of tested samples, and 17 isolates were identified as H5N1 through complete genome sequencing. Phylogenetic analysis revealed that all H5N1 viruses were closely related to Eurasian viruses and classified into three distinct genetic groups, suggesting multiple introductions likely linked to migratory birds. Experimental infections of chickens with two H5N1 isolates, A/Pintail/Egypt/RA19853OP/2021 and A/duck/Egypt/BA20361C/2022, showed efficient replication, systemic infection, and transmission by direct contact. These findings underscore the need for continued surveillance of H5N1 at the poultry-wild bird interface to identify circulating strains, evaluate their biological characteristics, and assess their zoonotic potential.

1. Introduction

The high genetic variability and rapid evolution of influenza viruses, particularly avian influenza viruses (AIVs), pose significant challenges to their prevention and control [1]. AIVs cause considerable morbidity and mortality in bird populations, with severity varying by subtype. AIVs belong to the genus Alphainfluenzavirus and family Orthomyxoviridae, with eight negative-sense single-stranded enveloped RNA segments [2], coding for at least 11 structural and non-structural/regulatory proteins [3]. Based on the antigenic characteristics of their surface glycoproteins, influenza viruses are classified into 16 hemagglutinin (H1–H16) and 9 neuraminidase (N1–N9) subtypes [4,5], with two novel influenza A virus subtypes, H17N10 and H18N11, genetically detected in bats [6]. Although all AIV subtypes were detected in aquatic birds, several subtypes, including H5, H6, H7, H9, and H10, can cross the species barrier to infect mammals.
It has been almost two decades since a highly pathogenic avian influenza (HPAI) virus subtype H5N1 was first detected in Egypt. Clade 2.2.1 H5N1 was introduced into Egyptian poultry in 2006, causing outbreaks in poultry and sporadic human infections. Its endemicity and continuous circulation in Egypt have driven further genetic and antigenic variations. Through active surveillance, we have since detected additional subclades emerging in Egypt, including 2.2.1.1, 2.2.1.2, and 2.2.1.1a [7,8].
In 2016, clade 2.3.4.4b H5N8 viruses were first reported in wild birds and poultry along Egypt’s Northern coast [9] and soon became predominant across poultry sectors including backyard flocks, commercial farms, and live bird markets (LBM) [10,11,12,13]. In 2020/2021, clade 2.3.4.4b H5N1 viruses spread across Europe, Africa, Asia, and the Americas and were predominantly circulating globally [14]. In Egypt, clade 2.3.4.4b H5N1 viruses were subsequently detected in wild birds and domestic ducks from LBMs [15] where they replaced earlier H5 strains. Furthermore, the coexistence and co-circulation of clade 2.3.4.4b HPAI H5N1 and low pathogenic avian influenza (LPAI) H9N2 viruses in Egypt have raised significant concern. In 2024, new reassortant clade 2.3.4.4b H5N2 viruses were detected in duck and environmental swabs in Egypt and were found to be genetically closely related to previously circulating viruses in Egyptian poultry [16].
Several studies demonstrated that LBMs are hotspots for the emergence, maintenance, and transmission of AIVs [17,18,19]. In Egypt, the mixing of wild and domestic birds within LBMs increases the risk of reassortment between HPAI and LPAI viruses and play a role in virus evolution. Previous studies showed that several introductions of clade 2.3.4.4b H5N8 and H5N1 viruses occurred in LBMs through wild birds [9,15]. Circulation of AIVs in LBMs increases infection risk for workers and the wider public [20,21]. Serological investigation has confirmed antibodies against HPAI H5N1 in poultry workers [22].
Infection with the novel H5N1 virus raised significant concerns about the pandemic potential of the H5 subtype. Therefore, extensive and long-term surveillance of AIVs in LBMs and wild birds is essential. In this study, we aimed to characterize the emerging clade 2.3.4.4b HPAI H5N1 genotypes detected in Egypt between 2021 and 2023 through our ongoing surveillance and assess their pathogenicity, replication, and direct transmission in infected specific pathogen-free (SPF) chickens.

2. Materials and Methods

2.1. Sample Collection

Between November 2021 and March 2023, a total of 940 oropharyngeal swabs and 940 cloacal swabs were collected from seven different LBMs in the north wetlands around the Nile Delta (2 in Port Said, 3 at Damietta, 1 at Kafr El-Shaikh, and 1 at Bahira Governorate). Those were selected for their proximity to wild nesting areas from which trapped birds are sold alongside poultry within the LBMs. At each visit, cloacal and oropharyngeal swabs were collected from five birds of each species present. We also collected environmental swab samples from surfaces, birds’ drinking water, market working surfaces, animal cages, and weighing scales. All swabs were placed into phosphate-buffered saline-glycerol (50%/50%) with penicillin (2 × 106 U/L), streptomycin (200 mg/L), and amphotericin B (250 mg/L) and kept at 4 °C during transport until reaching the lab by the end of each sampling day, then stored at −80 °C until use.

2.2. Virus Detection and Isolation

Viral nucleic acids were extracted using the MagMax viral/pathogen nucleic acid isolation kit (Applied Biosystems, Waltham, MA, USA) using the Kingfisher Flex Purification System as per manufacturer instructions. A total of 200 µL of each sample was extracted in a class III biosafety cabinet and then eluted in 50 µL elution buffer. Influenza A was detected for all samples using the WHO real-time RT-PCR membrane gene primers (M) assay using AgPath-ID One-Step RT-PCR kit (Applied Biosystems) [23]. Positive influenza A samples were subjected to viral isolation in 10–12-day-old SPF embryonated chicken eggs (SPF-ECE) (Koum Oshiem SPF chicken farm, Fayoum, Egypt). Influenza isolates were determined by hemagglutination activity using 0.5% chicken red blood cells [24]. Viruses were titrated by 50% egg infectious dose (EID50) and 50% tissue culture infectious dose (TCID50) according to the method of Reed and Muench [25].

2.3. Sequencing and Sequence Analysis

The first strand cDNA of H5N1 RNA isolates was generated using the first-strand synthesis Superscript IV kit (Invitrogen, Waltham, MA, USA) and the universal conserved Uni12/13 primers, then amplified with the primers for the influenza A full eight gene segments [26]. DNA amplicons were purified using GFX PCR DNA and gel bands purification kit (Cytiva Life Sciences, Marlborough, MA, USA). DNA sequence libraries were prepared using Nextera XT DNA-Seq library prep kits (Illumina, San Diego, CA, USA) according to the manufacturer’s instructions. Pooled libraries were sequenced using the MiniSeq Illumina genome sequencer with 150 nucleotide paired-end reads. Using reference genomes, sequencing reads were further analyzed using the CLC genomic workbench (Qiagen, Hilden, Germany). H5N1 viral sequences were aligned with Egyptian H5N1 sequences along with reference genomes retrieved from GISAID database using the ClustalW multiple alignment accessory application (BioEdit Sequence alignment editor version 7.2.5). Neighbor-joining phylogenetic tree for each genome segment was constructed using the MEGA X software [27], using Kimura’s two-parameter distance model and 1000 bootstraps. Accession numbers are listed in Table S1.

2.4. Viral Replication Kinetics in Mammalian Cell Lines

Madin-Darby canine kidney (MDCK) cells (ATCC, CCL-34) and human lung epithelial (A549) cells (ATCC, CCL-185) were obtained from the Center of Excellence for Influenza Research and Surveillance at St. Jude Children’s Research Hospital (Memphis, TN, USA) and used to determine the growth kinetics of two H5N1 isolates. A/Pintail/Egypt/RA19853OP/2021 (RA19853OP) and A/duck/Egypt/BA20361C/2022 (BA20361C) viruses were titrated in MDCK cells by plaque assay [24]. MDCK and A549 cells were grown in six-well plates with Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 1% antibiotic-antimycotic mixture and 5% inactivated fetal bovine serum (FBS) (Gibco, Waltham, MA, USA) at 37 °C and 5% CO2 in a humidified incubator. Confluent 80–90% cell monolayers were infected with 0.05 multiplicity of infection (MOI). After one hour of incubation at 37 °C, the viral inoculum was removed, cells were replenished with 3 mL/well of maintenance media (DMEM supplemented with 1% antibiotic mix (Gibco) and 4% bovine serum albumin (BSA) (Sigma, St. Louis, MO, USA), four replicates of the infected cells supernatants were harvested at 12, 24, 36, and 48 h post-infection (hpi), viral growth was determined with TCID50 assay then calculated using the Reed-Muench method [25].

2.5. Animal Experiment

2.5.1. Ethical Aspect

The National Research Center Research Ethics Committee approved all the animal studies (approval no: 06210123, approval date: 5 January 2023). All animal experiments were conducted in class III isolators. H5N1 experiments were performed under the guidelines of the Animal Care and Use Committee. Animals were anesthetized with ketamine anesthesia, and all efforts were made to minimize suffering. During the experiments, the animals would be euthanized via CO2 asphyxiation if they manifested severe symptoms, such as inactivity, loss of appetite, or loss of 30% or more of body weight.

2.5.2. Pathogenicity, Virulence, and Viral Shedding in SPF Chickens

A total of 120 SPF four-week-old Lohmann LSL white layers, purchased from Koum Oshiem SPF chicken farm, were divided into five groups (four for infection and one uninfected control). Two groups were infected intranasally with 0.5 mL of 106 EID50 of RA19853OP and BA20361C respectively, the other two infection groups were infected with 104 EID50/0.5mL of the same viruses, and the control group was inoculated with 0.5 mL PBS/chicken. In each cage, 13 chickens were inoculated with the corresponding virus (donor) and seven non-infected chickens (contact) were added to each infected group at 6 hpi. Cloacal and oropharyngeal swabs were collected from survived chickens at 1, 3, and 5 days post inoculation (dpi) for viral shedding assessment. At 3 and 5 dpi, two chickens of each group were humanely euthanized, and lungs, kidneys, intestines, and brains were collected for viral shedding examination and histopathological studies. We homogenized 0.1 g of each organ in 1 mL sterile PBS using the tissue lyse LT (Qiagen), spun at 1000× g for 10 min. Viral RNA was extracted from the swab samples and tissue homogenates using the MagMax viral/pathogen nucleic acid isolation kit (Applied Biosystems) and the Kingfisher Flex Purification System, and tested by RT-qPCR using primers and probes specific for the M gene. A 10-fold dilution series of titrated BA20361C and/or RA19853OP (known EID50 titer) virus was used to calculate viral titers, which are displayed as relative equivalency units (REUs), as previously described [28]. For histopathology, the 10% neutral buffered formalin solution-fixed organs were embedded in paraffin, sliced, fixed on microscopical slides, stained with hematoxylin and eosin (H&E), and examined histologically with a four-grade histopathological scale. The histopathological lesions were scored on a 0–4 scale. In the lung sections, a score of 0 indicates no lesion; 1, mild inflammation; 2, moderate inflammatory infiltration; 3, multifocal perivascular, peribronchiolar, or alveolar inflammation; and 4, diffuse parenchymal pneumonia with consolidation and/or hemorrhage. In the intestine, a score of 0 indicates normal mucosa; 1, mild degeneration of the villi; 2, moderate desquamation of epithelial cells; 3, focal lymphoid infiltration with eroded patches; and 4, marked villous atrophy and degenerated crypts. The histological lesions in the renal tissue (including glomerular atrophy, tubular epithelial exfoliation, and lymphoid infiltration) and the cerebral cortex (including neuronal apoptosis, microgliosis, and vascular congestion/dilatation) were also scored on a 0–4 scale (0 = no lesions, 1 = mild, 2 = moderate, 3 = severe, and 4 = very severe), as previously described [29]. The histopathological scoring was performed by two independent pathologists who were blinded to the groups.

2.5.3. Statistical Analysis

Significance of differences between tested groups and the control group was calculated using GraphPad Prism V8.0 software (GraphPad Inc., San Diego, CA, USA) by ANOVA with Bonferroni post hoc testing. Chi-square test was used to analyze the Epizootic variables, and Kaplan-Meyer test was used to compare survival. p-values < 0.05 were considered statistically significant.

3. Results

3.1. H5N1 Virus in Live Bird Markets

Overall, 20.94% (484/2311) of all tested samples were positive for influenza A. Influenza A was detected more significantly in oropharyngeal than cloacal samples, with 23.83% and 16.6%, respectively (p < 0.0001). Influenza A was detected in 17.26% of environmental surface samples, 31.84% of birds’ drinking water, and 18.18% of birds’ ambient air samples (Table 1). We identified 17 isolates as H5N1 with complete genome sequencing. H5N1 viruses were originally collected from different study sites from apparently healthy birds, mostly from ducks (four isolates from domestic ducks, seven from Muscovy ducks, and three from garganey ducks), one chicken, and one pigeon.

3.2. Phylogenetic Analysis and Sequence Similarity

Phylogenetic analysis of the HA gene revealed that Egyptian H5N1 HPAI viruses were closely related to recent HPAI viruses isolated from Eurasian countries. All isolates belonged to clade 2.3.4.4b and formed three distinct genetic groups (G1–G3), suggesting separate introductions of three genetically distinct viruses (Figure 1).
Viruses of the G1 cluster were closely related to clade 2.3.4.4b H5N1 HPAI viruses that shared a common ancestor with viruses detected in Europe and the Middle East [15]. Those appeared in 2021 and continued circulating in poultry in different sites, and most isolates from 2022–2023 were from the same cluster (Figure 1). A G2 virus was introduced by wild birds in 2022 and was closely related to a H5N1 HPAI virus identified in Russia in 2022. Two viruses, A/garganey/Egypt/DT20899OP/2022 and A/garganey/Egypt/DT20900OP/2022, were isolated in 2022 from wild birds and clustered together to form a distinct genetic group, G3, along with other viruses detected in the Middle East and Europe.
Similarly, the NA gene was also divided into three genetic groups (G1–G3) that were closely related to HPAI viruses identified in Eurasia (Figure 1). The phylogenetic analysis of the six internal viral genes was similar to the HA and NA genes of H5N1 HPAI viruses (Figure S1).

3.3. Molecular Characterization

We conducted analysis of amino acid sequences responsible for pathogenicity, adaptation to mammalian hosts, transmission in mammals, and antiviral resistance to understand the characteristics of Egyptian HPAI viruses during 2021–2023. The molecular characteristics of all 17 isolated H5N1 viruses were analyzed based on the whole-genome sequences. Based on the amino acid sequences of the HA genes, all 17 isolated H5N1 viruses possessed multi-basic cleavage site PLREKRRKR↓GLF (↓ denotes cleavage site), which is characteristic of HPAIVs (Table S2). The isolates had Q226 and G228 (H3 numbering) at the receptor-binding sites of the HA proteins, which suggested the avian-like α2,3-linked sialic acid (α2-3-SA) receptor binding preference. However, mammalian-adapting mutations such as the S158N (H3 numbering) substitution were detected. The E627K and D701N mutations within the PB2 protein, which are important for adaptation of AIVs to mammals [30,31], were not observed. Mutations in the NA protein, which is associated with resistance to oseltamivir (Table S2), were also not detected. None of the mutations at positions 26, 27, 30, 31, and 34 in the M2 protein that facilitate resistance to some anti-influenza drugs (i.e., M2 ion channel blockers) were detected. However, we found that all H5N1 contained P42S and V149A substitutions in the NS1 protein, which are associated with virulence and pathogenicity in mice and chickens, respectively [32,33].
Figure 1. Phylogenetic analysis of HA and NA genes of HPAI H5N1viruses detected in the Egyptian LBM between November 2021 and March 2023 as compared to reference gene sequences using MEGA X software through Neighbor-joining phylogenetic tree using Kimura’s two-parameter distance model and 1000 bootstraps. The viruses isolated in this study are shown in red and other Egyptian viruses are shown in blue.
Figure 1. Phylogenetic analysis of HA and NA genes of HPAI H5N1viruses detected in the Egyptian LBM between November 2021 and March 2023 as compared to reference gene sequences using MEGA X software through Neighbor-joining phylogenetic tree using Kimura’s two-parameter distance model and 1000 bootstraps. The viruses isolated in this study are shown in red and other Egyptian viruses are shown in blue.
Viruses 17 01370 g001aViruses 17 01370 g001b

3.4. Growth Kinetics of H5N1 Viruses in Mammalian Cells

To determine the replication of H5N1 viruses in mammalian cells lines, we compared the multicycle growth kinetics of the RA19853OP and BA20361C H5N1 viruses in MDCK and A549 cells. Both viruses replicated efficiently in both MDCK and A549 cells at MOI of 0.05. The viral titer of BA20361C was significantly higher than RA19853OP at 12 and 24 hpi on MDCK cells and 24 and 48 hpi on A549 cells (Figure 2). To identify the mutations potentially responsible for the increased replication of BA20361C in MDCK and A549 cells, we compared the full genomes of both viruses. Several mutations were detected in the PB1 (M688V), NP (K48R and S84N), and NA (S451V) proteins of BA20361C. Further experiments are needed to identify which of those mutations might be responsible for the differences in replication.

3.5. Replication and Virulence of the H5N1 Viruses in Chickens

To investigate the pathogenicity and transmission of H5N1 viruses in SPF chickens, we inoculated groups of chickens with 106 and 104 EID50 of each virus, then contact chickens were directly added at 6 hpi to the same cage. Seven inoculated SPF chickens, as well as the seven contact chickens in either virus group, were monitored for morbidity and mortality until 14 dpi. All chickens challenged with BA20361C died at 2 dpi, while chickens challenged with RA19853OP died at 3 dpi with 106 EID50 (Figure 3). Meanwhile, chickens challenged with 104 EID50 of BA20361 died at 3 dpi, and RA19853OP started to die between 4 and 8 dpi (Figure 3). The higher challenge dose was faster to kill all donor chickens for both viruses with statistically significant p-values (Figure 4).
Virus titers in cloacal and oropharyngeal swabs collected from chickens challenged with 106 EID50 of BA20361C rapidly peaked at 1 dpi (Figure 5). In contrast, vRNA titers in cloacal and oropharyngeal swabs of chickens challenged with 106 EID50 of RA19853OP at 1 and 3 dpi were detected before the death of the chickens, while in the chickens challenged with 104 EID50, the virus titers were detected until 5 dpi (Figure 5).
To investigate the transmission of H5N1 viruses, contact chickens were monitored and oropharyngeal and cloacal swabs were collected at 1, 3, and 5 dpi. The rate of transmission was 100%, and all chickens died following the exposure between 4 days post contact (dpc) and 8 dpc for both viruses, with two 106 EID50 and 104 EID50 (Figure 5). vRNA was detected by the oropharyngeal and cloacal swabs, and peak titer was 107.19 REU of EID50 for the chicken challenged with 106 EID50 of BA20361C at 1 dpi, and 107.82 REU of EID50 for those challenged with 104 EID50 at 3 dpc, along with the group challenged with RA19853OP (Figure 5).
To investigate the tissue tropism of H5N1 viruses, we collected organs from inoculated and contacted chickens with 104 EID50 of both two viruses at 3 dpi and at 5 dpi. vRNA was tested by M-gene RRT-PCR from a range of tissues obtained from two inoculated and contacted chickens. At 3 dpi, the vRNA was detected in all organs of inoculated chickens challenged with BA20361C and RA19853OP, with vRNA titers detected in lungs 103.27–3.59 REU of EID50, kidney 103.27–4.06 REU of EID50, brain 103.74–4.68 REU of EID50, and intestine 103.9 REU of EID50, while in the contact group, the virus shedding showed higher titers in all sampled organs (Figure 6A). For the RA19853OP, the vRNA was detected in all sampled organs of two chickens and detected in the kidney in one chicken with vRNA titer 106.25 REU of EID50 (Figure 6B). At 5dpi, we show that vRNA titers were detected in the lungs and brain in chickens inoculated with RA19853OP (Figure 6B).
Tissue tropism of H5N1 viruses was investigated in SPF chickens contacted with 106 EID50 of both viruses at 3 dpc and 5 dpc. Contacted chickens with 106 EID50 of BA20361C and RA19853OP displayed viral replication in all internal organs collected (lungs, kidneys, brain, and intestine), with vRNA titers of 103.4–8.1 REU of EID50 (Figure 6C). At 5 dpc, the organs were collected from one chicken of the contact group inoculated with RA19853OP, and the vRNA was detected in all organs with titers of 106.5–9.6 REU of EID50 (Figure 6C).

3.6. Histopathological Assessment of H5N1 Infection in Different Chicken Organs

Collected organs from euthanized non-infected chickens at 3 dpi were fixed, paraffin processed, and hematoxylin-eosin stained. Lungs of the uninfected controls appeared normal, with intact architecture, exhibiting normal morphological alveoli and bronchioles. The lungs of BA20361C infected and contact groups developed diffuse parenchymal pneumonia with lymphoid cellular infiltration. The RA19853OP infected chickens showed inflammatory consolidation with hemorrhagic pneumonia. There was notable bronchiectasis in the infected group and vascular thrombosis in the contact lungs (Figure 7a). The cerebral cortex of the uninfected chickens appeared structurally intact, with normal neuropil, neurons, and glial cells. The cerebral cortex of BA20361C and RA19853OP infected chickens displayed vascular dilatation and congestion. The contact groups showed numerous apoptotic neurons and glial cells (Figure 7b).
The intestinal tissue examination of the BA30361C infected and contacted chickens exhibits a lymphoid infiltration of the lamina propria, while those infected with RA19853OP and contacted chickens’ intestines appeared with degenerated crypts and villi. The control uninfected chickens’ intestines appeared to have no histopathological changes (Figure 7c). The kidneys of the BA20361C and RA19853OP infected chicken appeared with plain congestion of the interstitial capillaries. The BA20361C and RA19853OP contacted chicken unveiled atrophic glomeruli with tubular exfoliation in the BA20361C contact group and numerous lymphoid inflammatory cells in the RA19853OP contact group (Figure 7d). Overall, histopathological scores are comparable between infected and contacted chickens in both virus groups (Figure 7e).

4. Discussion

Egypt lies at the crossroads of the Black Sea–Mediterranean and East African–West Asian migratory flyways, which converge over the Nile Delta, bringing a high diversity of IAVs to Egypt. This convergence creates a “melting pot” of viruses, potentially leading to possible reassortment and emergence of new strains, including those with zoonotic potential. Many influenza viruses are endemic in Egyptian domestic poultry, including HPAI H5N1, H5N8, and LPAI H9N2 viruses, which, coupled with human exposure, increase the risk of reassortments and the emergence of new influenza strains.
In this study, we aimed to genetically and antigenically characterize H5N1 viruses isolated in Egypt though our active surveillance between 2021–2023. LBMs in coastal regions of Egypt are considered hotspots for virus transmission, mutation, and potential reassortment due to the direct contact between domestic poultry, captured migratory birds, stray animals, and humans. Swab samples were collected from birds and from environmental sources including birds’ drinking water, market working surfaces, animal cages, and weighing scales.
Influenza A viruses were detected in more than 20% of all samples. The majority of the H5N1 isolates were from apparently healthy ducks (one Pintail, three Garganey, four Pekin ducks, and six Muscovy ducks) highlighting the potential role of ducks in the transmission of HPAI. Besides isolation of H5 from different hosts, including migratory birds and various poultry species, phylogenetic and genetic analyses revealed that all H5N1 viruses belonged to clade 2.3.4.4b Eurasian-like viruses, forming three different genetic groups, and suggesting multiple sequential introductions of genetically distinct viruses into Egypt. The spread of these variants in multiple species and geographical locations simultaneously may facilitate reassortment events as previously reported [16,34,35].
The collective genetic characteristics of those three distinct H5N1 genetic groups with the typical cleavage site PLREKRRKR↓GLF presented the Q226 and the G228 amino acid residues at the receptor binding site of the HA that favor binding to α2,3-linked sialic acid (α2-3-SA) receptors [36,37,38]. However, some substitutions associated with mammalian adaptation were also detected, such as S158N in the HA protein [39,40,41,42] and P42S in the NS1 protein linked to enhanced virulence and pathogenicity in mammals. The L222 and S224 in HA, associated with human-like receptor binding, and E627K and D701N in PB2, associated with mammalian adaptation and increased polymerase activity, were not found in our H5N1 isolates. The characterized H5N1 viruses showed high genetic similarity to an H5N1 strain isolated from a rat in Egypt in 2023 [43], further supporting the hypothesis that these viruses are undergoing adaptation to mammalian hosts.
Antiviral resistance markers were not detected in the H5N1 isolates, including E119V, H275Y, R293K, and N295S, which are known to reduce susceptibility to neuraminidase inhibitors, predominantly oseltamivir. Resistance markers to adamantane-based antivirals like amantadine and rimantadine, including L26F, V27A, A30T, G34E, and L38F of the M protein, were absent. However, the S31N substitution, which is known to confer resistance by disrupting M2 ion channel binding to adamantane drugs was present.
Wild birds and domestic ducks are key players in the maintenance, transmission, and reassortment of influenza viruses at the wild–domestic interface [16,44,45]. We investigated viral the shedding dynamics and transmission of two isolates from wild birds and domestic ducks from a distinct genetic group, G1. The two viruses exhibited high pathogenicity and virulence in the chicken model, resulting in 100% mortality by 2 and 3 dpi with an infectious dose of 106 EID50. Similarly, contacted chickens exposed to infected birds also experienced complete mortality, albeit with delayed onset at 4 and 8 dpi. The same trend was observed with the lower infection dose (104 EID50), where infected chickens showed delayed mortality by one additional day. These results slightly support the dose-dependent effect on infectivity, pathology, and virulence, but not on overall survival [46,47].
Higher viral shedding was detected for BA20361C than RA19853OP in the infected chickens’ oral and cloacal swabs, indicating a high transmission rate that aligns with the observed survival rates of infected and contacted chickens. Both viruses replicated systemically in SPF chickens; the RA19853OP replicated more efficiently than the BA20361C in the organs of contact chickens infected with 106 EID50 at 3 and 5 dpi. This trend was reversed in contact chickens at 3 dpi, where BA20361C actively replicated more than RA19853OP. Histopathological analysis showed comparable tissue damage and pathological scores between chickens infected with either virus, with minor differences observed.
In conclusion, three genetically distinct groups of HPAI H5N1 viruses were detected in poultry and migrant birds, with the competence to cause systemic infection and direct infections in chickens. Therefore, intensified virological surveillance, particularly in high-risk settings such as LBMs, where animals are in direct contact with humans, is essential, along with monitoring of the genetic and pathogenic characteristics of AIV.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/v17101370/s1, Table S1: GenBank Accession Number of HPAI A(H5N1) viruses sequenced in this study. Table S2: Molecular characteristics of H5N1 HPAI viruses isolated in this study. Figure S1: Phylogenetic analysis of PB2, PB1, PA, NP, M, and NS genes of HPAI H5N1 viruses detected in the Egyptian LBM between November 2021 and March 2023 as compared to reference gene sequences using MEGA X software through Neighbor-joining phylogenetic tree using Kimura’s two-parameter distance model and 1000 bootstraps.

Author Contributions

Conceptualization, M.A.A., G.K. and R.E.-S.; methodology, M.N.K., Y.M., M.G. (Mokhtar Gomaa), A.E.T., O.K. and R.E.-S.; software, M.N.K., Y.M. and R.E.-S.; formal analysis, M.N.K., Y.M., B.E.A., H.A. and R.E.-S.; investigation, M.N.K., Y.M., B.E.A., M.G. (Mokhtar Gomaa), A.E.T., O.K., M.E.S., M.G. (Mohamed GabAllah), H.A. and R.E.-S.; data curation, A.K., P.P.M., R.J.W., M.A.A., G.K. and R.E.-S.; writing—original draft preparation, M.N.K., Y.M., M.G. (Mokhtar Gomaa), A.K. and R.E.-S.; writing—review and editing, M.A.A., G.K. and R.E.-S.; supervision, R.M.G., M.M.A., M.A.A., G.K. and R.E.-S.; project administration, P.P.M. and G.K.; funding acquisition, R.J.W., M.A.A., G.K. and R.E.-S. All authors have read and agreed to the published version of the manuscript.

Funding

This study was financially supported by the STDF for the research fund under the Center of Scientific Excellence upgrading Fund (46654). The sample collection and genetic characterization components of this research were funded in part by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services (contract no. 75N93021C00016).

Institutional Review Board Statement

The animal study protocol was approved by the Medical Research Ethics Committee of the National Research Centre (approval no: 06210123, approved on 5 January 2023).

Data Availability Statement

The data supporting the findings of this study are available in the manuscript and supplementary material.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

Abbreviations

The following abbreviations are used in this manuscript:
AIVAvian influenza viruses
BSABovine serum albumin
DPCDays post contact
DPIDays post inoculation
DMEMDulbecco’s Modified Eagle’s Medium
H&Ehematoxylin and eosin
HPAIhighly pathogenic avian influenza
LBMlive bird market
LPAIlow pathogenic avian influenza
MDCKMadin-Darby canine kidney
SPFspecific pathogen-free
EID5050% egg infectious dose
TCID5050% tissue culture infectious dose

References

  1. Duan, C.; Li, C.; Ren, R.; Bai, W.; Zhou, L. An overview of avian influenza surveillance strategies and modes. Sci. One Health 2023, 2, 100043. [Google Scholar] [CrossRef]
  2. Howley, P.M.; Knipe, D.M.; Whelan, S.P.J. Fields Virology: Emerging Viruses, 7e. Lippincott Williams & Wilkins, a Wolters Kluwer business. 2021. Available online: https://internalmedicine.lwwhealthlibrary.com/book.aspx?bookid=2918&sectionid=0 (accessed on 13 August 2025).
  3. McCrone, J.T.; Woods, R.J.; Martin, E.T.; Malosh, R.E.; Monto, A.S.; Lauring, A.S. Stochastic processes constrain the within and between host evolution of influenza virus. eLife 2018, 7, e35962. [Google Scholar] [CrossRef]
  4. Yewdell, J.W.; Webster, R.G.; Gerhard, W.U. Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule. Nature 1979, 279, 246–248. [Google Scholar] [CrossRef]
  5. Webster, R.G.; Bean, W.J.; Gorman, O.T.; Chambers, T.M.; Kawaoka, Y. Evolution and ecology of influenza A viruses. Microbiol. Rev. 1992, 56, 152–179. [Google Scholar] [CrossRef]
  6. Tong, S.; Zhu, X.; Li, Y.; Shi, M.; Zhang, J.; Bourgeois, M.; Yang, H.; Chen, X.; Recuenco, S.; Gomez, J. New world bats harbor diverse influenza A viruses. PLoS Pathog. 2013, 9, e1003657. [Google Scholar] [CrossRef] [PubMed]
  7. El-Shesheny, R.; Kandeil, A.; Bagato, O.; Maatouq, A.M.; Moatasim, Y.; Rubrum, A.; Song, M.-S.; Webby, R.J.; Ali, M.A.; Kayali, G. Molecular characterization of avian influenza H5N1 virus in Egypt and the emergence of a novel endemic subclade. J. Gen. Virol. 2014, 95, 1444–1463. [Google Scholar] [CrossRef] [PubMed]
  8. Kayali, G.; Webby, R.J.; Ducatez, M.F.; El Shesheny, R.A.; Kandeil, A.M.; Govorkova, E.A.; Mostafa, A.; Ali, M.A. The epidemiological and molecular aspects of influenza H5N1 viruses at the human-animal interface in Egypt. PLoS ONE 2011, 6, e17730. [Google Scholar] [CrossRef]
  9. Kandeil, A.; Kayed, A.; Moatasim, Y.; Webby, R.J.; McKenzie, P.P.; Kayali, G.; Ali, M.A. Genetic characterization of highly pathogenic avian influenza A H5N8 viruses isolated from wild birds in Egypt. J. Gen. Virol. 2017, 98, 1573–1586. [Google Scholar] [CrossRef]
  10. Kandeil, A.; Moatasim, Y.; El Taweel, A.; El Sayes, M.; Rubrum, A.; Jeevan, T.; McKenzie, P.P.; Webby, R.J.; Ali, M.A.; Kayali, G.; et al. Genetic and Antigenic Characteristics of Highly Pathogenic Avian Influenza A(H5N8) Viruses Circulating in Domestic Poultry in Egypt, 2017–2021. Microorganisms 2022, 10, 595. [Google Scholar] [CrossRef] [PubMed]
  11. Moatasim, Y.; Aboulhoda, B.E.; Gomaa, M.; El Taweel, A.; Kutkat, O.; Kamel, M.N.; El Sayes, M.; GabAllah, M.; Elkhrsawy, A.; AbdAllah, H.; et al. Genetic and pathogenic potential of highly pathogenic avian influenza H5N8 viruses from live bird markets in Egypt in avian and mammalian models. PLoS ONE 2024, 19, e0312134. [Google Scholar] [CrossRef]
  12. Kandeil, A.; Hicks, J.T.; Young, S.G.; El Taweel, A.N.; Kayed, A.S.; Moatasim, Y.; Kutkat, O.; Bagato, O.; McKenzie, P.P.; Cai, Z.; et al. Active surveillance and genetic evolution of avian influenza viruses in Egypt, 2016–2018. Emerg. Microbes Infect. 2019, 8, 1370–1382. [Google Scholar] [CrossRef]
  13. Abdel-Ghany, A.A.M.; El Taweel, A.N.; Moatasim, Y.; Ata, N.S.; Adel, A.; El-Deeb, A.H.; Kandeil, A.; Ali, M.A.; Hussein, H.A. Prevalence of Two Distinct Genotypes of Highly Pathogenic Avian Influenza A/H5N8 Viruses in Backyard Waterfowls in Upper Egypt During 2018. Adv. Anim. Vet. Sci. 2023, 11, 820–831. [Google Scholar] [CrossRef]
  14. Cui, P.; Shi, J.; Wang, C.; Zhang, Y.; Xing, X.; Kong, H.; Yan, C.; Zeng, X.; Liu, L.; Tian, G.; et al. Global dissemination of H5N1 influenza viruses bearing the clade 2.3.4.4b HA gene and biologic analysis of the ones detected in China. Emerg. Microbes Infect. 2022, 11, 1693–1704. [Google Scholar] [CrossRef]
  15. El-Shesheny, R.; Moatasim, Y.; Mahmoud, S.H.; Song, Y.; El Taweel, A.; Gomaa, M.; Kamel, M.N.; Sayes, M.E.; Kandeil, A.; Lam, T.T.Y.; et al. Highly Pathogenic Avian Influenza A(H5N1) Virus Clade 2.3.4.4b in Wild Birds and Live Bird Markets, Egypt. Pathogens 2022, 12, 36. [Google Scholar] [CrossRef]
  16. El-Shesheny, R.; Gomaa, M.; Sayes, M.E.; Kamel, M.N.; Taweel, A.E.; Kutkat, O.; GabAllah, M.; Elkhrsawy, A.; Emam, H.; Moatasim, Y.; et al. Emergence of a novel reassortant highly pathogenic avian influenza clade 2.3.4.4b A(H5N2) Virus, 2024. Emerg. Microbes Infect. 2025, 14, 2455601. [Google Scholar] [CrossRef] [PubMed]
  17. Wen, F.; Yang, Y.; Li, Y.; Guo, J.; Li, Z.; Liu, L.; Liu, H.; Mei, K.; Qin, L.; Zhang, K.; et al. Novel human-type receptor-binding H5N1 virus in live poultry markets, China. Lancet Microbe 2025, 6, 101049. [Google Scholar] [CrossRef]
  18. Wang, M.; Di, B.; Zhou, D.H.; Zheng, B.J.; Jing, H.; Lin, Y.P.; Liu, Y.F.; Wu, X.W.; Qin, P.Z.; Wang, Y.L.; et al. Food markets with live birds as source of avian influenza. Emerg. Infect. Dis. 2006, 12, 1773–1775. [Google Scholar] [CrossRef]
  19. Amonsin, A.; Choatrakol, C.; Lapkuntod, J.; Tantilertcharoen, R.; Thanawongnuwech, R.; Suradhat, S.; Suwannakarn, K.; Theamboonlers, A.; Poovorawan, Y. Influenza virus (H5N1) in live bird markets and food markets, Thailand. Emerg. Infect. Dis. 2008, 14, 1739–1742. [Google Scholar] [CrossRef]
  20. Jadhao, S.J.; Nguyen, D.C.; Uyeki, T.M.; Shaw, M.; Maines, T.; Rowe, T.; Smith, C.; Huynh, L.P.; Nghiem, H.K.; Nguyen, D.H.; et al. Genetic analysis of avian influenza A viruses isolated from domestic waterfowl in live-bird markets of Hanoi, Vietnam, preceding fatal H5N1 human infections in 2004. Arch. Virol. 2009, 154, 1249–1261. [Google Scholar] [CrossRef]
  21. Pinotti, F.; Kohnle, L.; Lourenço, J.; Gupta, S.; Hoque, M.A.; Mahmud, R.; Biswas, P.; Pfeiffer, D.; Fournié, G. Modelling the transmission dynamics of H9N2 avian influenza viruses in a live bird market. Nat. Commun. 2024, 15, 3494. [Google Scholar] [CrossRef] [PubMed]
  22. Gomaa, M.; Moatasim, Y.; El Taweel, A.; Mahmoud, S.H.; El Rifay, A.S.; Kandeil, A.; McKenzie, P.P.; Webby, R.J.; El-Shesheny, R.; Ali, M.A.; et al. We are underestimating, again, the true burden of H5N1 in humans. BMJ Glob. Health 2023, 8, e013146. [Google Scholar] [CrossRef] [PubMed]
  23. WHO. WHO Information for the Molecular Detection of Influenza Viruses. Available online: https://cdn.who.int/media/docs/default-source/influenza/molecular-detention-of-influenza-viruses/protocols_influenza_virus_detection_2024.pdf?sfvrsn=df7d268a_8 (accessed on 10 August 2025).
  24. WHO. WHO Manual on Animal Influenza Diagnosis and Surveillance. Available online: https://iris.who.int/server/api/core/bitstreams/2c04b1a7-27e4-44ab-9a88-3db0ff51bbb1/content (accessed on 10 August 2025).
  25. Reed, L.J.; Muench, H. A Simple Method of Estimating Fifty Per Cent Endpoints. Am. J. Epidemiol. 1938, 27, 493–497. [Google Scholar] [CrossRef]
  26. Hoffmann, E.; Stech, J.; Guan, Y.; Webster, R.G.; Perez, D.R. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 2001, 146, 2275–2289. [Google Scholar] [CrossRef]
  27. Kumar, S.; Stecher, G.; Li, M.; Knyaz, C.; Tamura, K. MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. Mol. Biol. Evol. 2018, 35, 1547–1549. [Google Scholar] [CrossRef]
  28. Bhat, S.; James, J.; Sadeyen, J.R.; Mahmood, S.; Everest, H.J.; Chang, P.; Walsh, S.K.; Byrne, A.M.P.; Mollett, B.; Lean, F.; et al. Coinfection of Chickens with H9N2 and H7N9 Avian Influenza Viruses Leads to Emergence of Reassortant H9N9 Virus with Increased Fitness for Poultry and a Zoonotic Potential. J. Virol. 2022, 96, e0185621. [Google Scholar] [CrossRef]
  29. Kutkat, O.; Gomaa, M.; Aboulhoda, B.E.; Moatasim, Y.; El Taweel, A.; Kamel, M.N.; El Sayes, M.; Elkhrsawy, A.; AbdAllah, H.; Kandeil, A.; et al. Genetic and virological characteristics of a reassortant avian influenza A H6N1 virus isolated from wild birds at a live-bird market in Egypt. Arch. Virol. 2024, 169, 95. [Google Scholar] [CrossRef]
  30. Li, Z.; Chen, H.; Jiao, P.; Deng, G.; Tian, G.; Li, Y.; Hoffmann, E.; Webster, R.G.; Matsuoka, Y.; Yu, K. Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J. Virol. 2005, 79, 12058–12064. [Google Scholar] [CrossRef]
  31. Shinya, K.; Hamm, S.; Hatta, M.; Ito, H.; Ito, T.; Kawaoka, Y. PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. Virology 2004, 320, 258–326. [Google Scholar] [CrossRef] [PubMed]
  32. Forbes, N.E.; Ping, J.; Dankar, S.K.; Jia, J.J.; Selman, M.; Keleta, L.; Zhou, Y.; Brown, E.G. Multifunctional adaptive NS1 mutations are selected upon human influenza virus evolution in the mouse. PLoS ONE 2012, 7, e31839. [Google Scholar] [CrossRef]
  33. Jiao, P.; Tian, G.; Li, Y.; Deng, G.; Jiang, Y.; Liu, C.; Liu, W.; Bu, Z.; Kawaoka, Y.; Chen, H. A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J. Virol. 2008, 82, 1146–1154. [Google Scholar] [CrossRef]
  34. Hagag, N.M.; Erfan, A.M.; El-Husseiny, M.; Shalaby, A.G.; Saif, M.A.; Tawakol, M.M.; Nour, A.A.; Selim, A.A.; Arafa, A.S.; Hassan, M.K.; et al. Isolation of a Novel Reassortant Highly Pathogenic Avian Influenza (H5N2) Virus in Egypt. Viruses 2019, 11, 565. [Google Scholar] [CrossRef]
  35. Hassan, K.E.; King, J.; El-Kady, M.; Afifi, M.; Abozeid, H.H.; Pohlmann, A.; Beer, M.; Harder, T. Novel Reassortant Highly Pathogenic Avian Influenza A(H5N2) Virus in Broiler Chickens, Egypt. Emerg. Infect. Dis. 2020, 26, 129–133. [Google Scholar] [CrossRef] [PubMed]
  36. Chen, H.; Smith, G.J.; Li, K.S.; Wang, J.; Fan, X.H.; Rayner, J.M.; Vijaykrishna, D.; Zhang, J.X.; Zhang, L.J.; Guo, C.T.; et al. Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic control. Proc. Natl. Acad. Sci. USA 2006, 103, 2845–2850. [Google Scholar] [CrossRef] [PubMed]
  37. Ha, Y.; Stevens, D.J.; Skehel, J.J.; Wiley, D.C. X-ray structures of H5 avian and H9 swine influenza virus hemagglutinins bound to avian and human receptor analogs. Proc. Natl. Acad. Sci. USA 2001, 98, 11181–11186. [Google Scholar] [CrossRef]
  38. Jiao, P.; Song, Y.; Yuan, R.; Wei, L.; Cao, L.; Luo, K.; Liao, M. Complete genomic sequence of an H5N1 influenza virus from a parrot in southern China. J. Virol. 2012, 86, 8894–8895. [Google Scholar] [CrossRef]
  39. Hu, W. Receptor binding specificity and sequence comparison of a novel avian-origin H7N9 virus in China. J. Biomed. Sci. Eng. 2013, 6, 533–542. [Google Scholar] [CrossRef]
  40. Gao, R.; Gu, M.; Shi, L.; Liu, K.; Li, X.; Wang, X.; Hu, J.; Liu, X.; Hu, S.; Chen, S. N-linked glycosylation at site 158 of the HA protein of H5N6 highly pathogenic avian influenza virus is important for viral biological properties and host immune responses. Vet. Res. 2021, 52, 8. [Google Scholar] [CrossRef]
  41. Peacock, T.P.; Harvey, W.T.; Sadeyen, J.-R.; Reeve, R.; Iqbal, M. The molecular basis of antigenic variation among A (H9N2) avian influenza viruses. Emerg. Microbes Infect. 2018, 7, 1–12. [Google Scholar] [CrossRef]
  42. Wang, W.; Lu, B.; Zhou, H.; Suguitan, A.L., Jr.; Cheng, X.; Subbarao, K.; Kemble, G.; Jin, H. Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets. J. Virol. 2010, 84, 6570–6577. [Google Scholar] [CrossRef] [PubMed]
  43. Kutkat, O.; Gomaa, M.; Moatasim, Y.; El Taweel, A.; Kamel, M.N.; El Sayes, M.; GabAllah, M.; Kandeil, A.; McKenzie, P.P.; Webby, R.J.; et al. Highly pathogenic avian influenza virus H5N1 clade 2.3.4.4b in wild rats in Egypt during 2023. Emerg. Microbes Infect. 2024, 13, 2396874. [Google Scholar] [CrossRef]
  44. Verhagen, J.H.; Fouchier, R.A.M.; Lewis, N. Highly Pathogenic Avian Influenza Viruses at the Wild-Domestic Bird Interface in Europe: Future Directions for Research and Surveillance. Viruses 2021, 13, 212. [Google Scholar] [CrossRef]
  45. El-Shesheny, R.; Barman, S.; Feeroz, M.M.; Hasan, M.K.; Jones-Engel, L.; Franks, J.; Turner, J.; Seiler, P.; Walker, D.; Friedman, K.; et al. Genesis of Influenza A(H5N8) Viruses. Emerg. Infect. Dis. 2017, 23, 1368–1371. [Google Scholar] [CrossRef] [PubMed]
  46. Vasudevan, G.; Vanamayya, P.R.; Nagarajan, S.; Rajukumar, K.; Suba, S.; Venketash, G.; Tosh, C.; Sood, R.; Nissly, R.H.; Kuchipudi, S.V. Infectious dose-dependent accumulation of live highly pathogenic avian influenza H5N1 virus in chicken skeletal muscle-implications for public health. Zoonoses Public Health 2018, 65, e243–e247. [Google Scholar] [CrossRef] [PubMed]
  47. Kitajima, M.; Huang, Y.; Watanabe, T.; Katayama, H.; Haas, C.N. Dose-response time modelling for highly pathogenic avian influenza A (H5N1) virus infection. Lett. Appl. Microbiol. 2011, 53, 438–444. [Google Scholar] [CrossRef] [PubMed]
Figure 2. Growth kinetics of H5N1 viruses in MDCK (A) and A549 (B) cells. Cells were inoculated at a multiplicity of infection of 0.05 TCID50/cell with the A/Pintail/Egypt/RA19853OP/2021 or A/duck/Egypt/BA20361C/2022. Supernatants were collected at the indicated time points and titrated in MDCK cells by TCID50. Error bars depict standard deviations. ** p  <  0.01, **** p  <  0.0001.
Figure 2. Growth kinetics of H5N1 viruses in MDCK (A) and A549 (B) cells. Cells were inoculated at a multiplicity of infection of 0.05 TCID50/cell with the A/Pintail/Egypt/RA19853OP/2021 or A/duck/Egypt/BA20361C/2022. Supernatants were collected at the indicated time points and titrated in MDCK cells by TCID50. Error bars depict standard deviations. ** p  <  0.01, **** p  <  0.0001.
Viruses 17 01370 g002
Figure 3. Survival curves for inoculated and contact SPF chickens with 104 (A,B) and 106 (C,D) EID50. Seven 4-week-old chickens were inoculated with the A/Pintail/Egypt/RA19853OP/2021 or A/duck/Egypt/BA20361C/2022 and seven naïve chickens were cohoused with the inoculated chickens at 6 h post inoculation. The chickens were monitored for signs of illness or death over a period of 14 d following the inoculation.
Figure 3. Survival curves for inoculated and contact SPF chickens with 104 (A,B) and 106 (C,D) EID50. Seven 4-week-old chickens were inoculated with the A/Pintail/Egypt/RA19853OP/2021 or A/duck/Egypt/BA20361C/2022 and seven naïve chickens were cohoused with the inoculated chickens at 6 h post inoculation. The chickens were monitored for signs of illness or death over a period of 14 d following the inoculation.
Viruses 17 01370 g003
Figure 4. Survival curves comparing dose effect of each challenge virus in donor chickens, BA20361C (A) and RA19853OP (B). The higher dose had a significantly shorter time to death.
Figure 4. Survival curves comparing dose effect of each challenge virus in donor chickens, BA20361C (A) and RA19853OP (B). The higher dose had a significantly shorter time to death.
Viruses 17 01370 g004
Figure 5. Viral shedding titers obtained from SPF chickens inoculated/contacted with 104 (A,B) and 106 (C,D) EID50 of A/Pintail/Egypt/RA19853OP/2021 or A/duck/Egypt/BA20361C/2022. Viral titers (shown as relative equivalence units [REUs] of 50% egg infectious dose [EID50]) were determined by using the M-gene RRT-PCR. Dotted horizontal lines indicate the M-gene RRT-PCR positive cut-off.
Figure 5. Viral shedding titers obtained from SPF chickens inoculated/contacted with 104 (A,B) and 106 (C,D) EID50 of A/Pintail/Egypt/RA19853OP/2021 or A/duck/Egypt/BA20361C/2022. Viral titers (shown as relative equivalence units [REUs] of 50% egg infectious dose [EID50]) were determined by using the M-gene RRT-PCR. Dotted horizontal lines indicate the M-gene RRT-PCR positive cut-off.
Viruses 17 01370 g005
Figure 6. Viral titers in lung, kidney, brain, and intestine tissues of inoculated/contacted chickens at 3 and 5 days postinfection (dpi) with 104 (A,B) and contacted chickens with 106 (C) EID50 of A/Pintail/Egypt/RA19853OP/2021 or A/duck/Egypt/BA20361C/2022. Viral titers (shown as relative equivalence units [REUs] of 50% egg infectious dose [EID50]) were determined by using the M-gene RRT-PCR. Dotted horizontal lines indicate the M-gene RRT-PCR positive cut-off.
Figure 6. Viral titers in lung, kidney, brain, and intestine tissues of inoculated/contacted chickens at 3 and 5 days postinfection (dpi) with 104 (A,B) and contacted chickens with 106 (C) EID50 of A/Pintail/Egypt/RA19853OP/2021 or A/duck/Egypt/BA20361C/2022. Viral titers (shown as relative equivalence units [REUs] of 50% egg infectious dose [EID50]) were determined by using the M-gene RRT-PCR. Dotted horizontal lines indicate the M-gene RRT-PCR positive cut-off.
Viruses 17 01370 g006
Figure 7. Hematoxylin and eosin (H&E) staining and pathological quantification of chicken tissue of (a) control group showing normal lung alveoli and bronchioles. The BA20361C infected and contact groups show marked interstitial pneumonia with lymphoid cellular infiltration (I). The RA19853OP chicken shows hemorrhagic pneumonia (H) with areas of bronchiectasis (B) in the infected group and vascular thrombosis (T) in the contact group. (b) The control chicken displays an intact structure of the cerebral cortex. The BA20361C and RA19853OP infected groups show vascular dilatation and congestion (V). The contact groups show numerous apoptotic neurons (A) and glial cells (G). (c) The intestinal tissue of the BA20361C infected and contact groups revealed lymphoid infiltration of the lamina propria (L). The RA19853OP infected and contacted chickens show degenerated crypts and villi (D). (d) The kidney sections of the BA20361C and RA19853OP infected chicken show marked congestion of the interstitial capillaries (curved arrows). The BA20361C and RA19853OP contacted chicken show atrophic glomeruli (G) with tubular exfoliation (E) in the BA20361C contact group and numerous lymphoid inflammatory cells (L) in the RA19853OP contact group. (e) Histopathological scoring. *: significant versus control, #: significant versus BA20361C infected, @: significant versus BA20361C contact at (p < 0.05) using ANOVA, Bonferroni post hoc testing.
Figure 7. Hematoxylin and eosin (H&E) staining and pathological quantification of chicken tissue of (a) control group showing normal lung alveoli and bronchioles. The BA20361C infected and contact groups show marked interstitial pneumonia with lymphoid cellular infiltration (I). The RA19853OP chicken shows hemorrhagic pneumonia (H) with areas of bronchiectasis (B) in the infected group and vascular thrombosis (T) in the contact group. (b) The control chicken displays an intact structure of the cerebral cortex. The BA20361C and RA19853OP infected groups show vascular dilatation and congestion (V). The contact groups show numerous apoptotic neurons (A) and glial cells (G). (c) The intestinal tissue of the BA20361C infected and contact groups revealed lymphoid infiltration of the lamina propria (L). The RA19853OP infected and contacted chickens show degenerated crypts and villi (D). (d) The kidney sections of the BA20361C and RA19853OP infected chicken show marked congestion of the interstitial capillaries (curved arrows). The BA20361C and RA19853OP contacted chicken show atrophic glomeruli (G) with tubular exfoliation (E) in the BA20361C contact group and numerous lymphoid inflammatory cells (L) in the RA19853OP contact group. (e) Histopathological scoring. *: significant versus control, #: significant versus BA20361C infected, @: significant versus BA20361C contact at (p < 0.05) using ANOVA, Bonferroni post hoc testing.
Viruses 17 01370 g007
Table 1. Epizootic variables of H5N1 isolated viruses in live bird markets. p-values indicate differences in influenza A positivity between categories.
Table 1. Epizootic variables of H5N1 isolated viruses in live bird markets. p-values indicate differences in influenza A positivity between categories.
VariablesTotal Tested
N (%)
Positive Influenza A
Realtime RT-PCR
N (%)
H5N1
Isolates
N (%)
p Value
Sample type (Total)2311 (100.00)484 (20.94)17 (0.736)<0.0001
Oropharyngeal940 (40.67)224 (23.83)11 (1.17)
Cloacal940 (40.67)156(16.6)5 (0.532)
Surface197 (8.52)34 (17.26)1 (0.51)
Water201 (8.69)64 (31.84)0 (0.00)
Air33 (1.42)6 (18.18)0 (0.00)
Site (Total)2311 (100.00)484 (20.94)17 (0.736)0.0088
Port Said447 (19.34)89 (19.91)5 (1.12)
Damietta878 (37.99)166 (18.9)2 (0.91)
Kafr El-Shaikh461 (19.94)130 (28.2)5 (1.085)
Bahira525 (22.72)99 (18.85)5 (0.952)
Health1880 (100.00)380 (20.21)16 (0.85)NS
Healthy1878 (99.98)379 (20.18)16 (0.85)
Sick0 (0.00)0 (0.00)0 (0.00)
Dead2 (0.12)1 (50.00)0 (0.00)
Species1880 (100.00)380 (20.21)16 (0.85)<0.0001
Black-legged kittiwake6 (0.32)2 (33.33)0 (0.00)
Cattle egret2 (0.12)0 (0.00)0 (0.00)
Chicken688 (36.59)162 (23.54)1 (0.15)
Common Myna2 (0.12)0 (0.00)0 (0.00)
Common pochard62 (3.29)7 (11.29)0 (0.00)
Common Quail140 (7.44)28 (20)0 (0.00)
Coot30 (1.59)1 (3.33)0 (0.00)
Duck104 (5.53)36 (34.61)4 (3.99)
Egyptian turtle dove10 (0.53)0 (0.00)0 (0.00)
Eurasian golden oriole14 (0.74)1 (7.14)0 (0.00)
Garganey178 (9.46)37 (20.78)3 (1.69)
Hoopoe2 (0.12)0 (0.00)0 (0.00)
Mallard44 (2.34)6 (13.63)0 (0.00)
Moorhen134 (7.12)15 (11.19)0 (0.00)
Muscovy Duck10 (0.53)8 (80)6 (6.00)
Northern shoveler156 (8.29)35 (22.43)0 (0.00)
Pigeon164 (8.72)7 (4.26)1 (0.61)
Pintail86 (4.57)21 (24.41)1 (1.16)
Purple swamphen10 (0.53)7 (70)0 (0.00)
Ruff16 (0.85)1 (6.25)0 (0.00)
Saker falcon10 (0.53)2 (20)0 (0.00)
Turkey10 (0.53)4 (40)0 (0.00)
Wigeon2 (0.12)0 (0.00)0 (0.00)
NS = not significant.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kamel, M.N.; Moatasim, Y.; Aboulhoda, B.E.; Gomaa, M.; El Taweel, A.; Kutkat, O.; El Sayes, M.; GabAllah, M.; AbdAllah, H.; Gabre, R.M.; et al. Genetic Characterization and Pathogenesis of Highly Pathogenic Avian Influenza Virus A (H5N1) Isolated in Egypt During 2021–2023. Viruses 2025, 17, 1370. https://doi.org/10.3390/v17101370

AMA Style

Kamel MN, Moatasim Y, Aboulhoda BE, Gomaa M, El Taweel A, Kutkat O, El Sayes M, GabAllah M, AbdAllah H, Gabre RM, et al. Genetic Characterization and Pathogenesis of Highly Pathogenic Avian Influenza Virus A (H5N1) Isolated in Egypt During 2021–2023. Viruses. 2025; 17(10):1370. https://doi.org/10.3390/v17101370

Chicago/Turabian Style

Kamel, Mina Nabil, Yassmin Moatasim, Basma Emad Aboulhoda, Mokhtar Gomaa, Ahmed El Taweel, Omnia Kutkat, Mohamed El Sayes, Mohamed GabAllah, Hend AbdAllah, Refaat M. Gabre, and et al. 2025. "Genetic Characterization and Pathogenesis of Highly Pathogenic Avian Influenza Virus A (H5N1) Isolated in Egypt During 2021–2023" Viruses 17, no. 10: 1370. https://doi.org/10.3390/v17101370

APA Style

Kamel, M. N., Moatasim, Y., Aboulhoda, B. E., Gomaa, M., El Taweel, A., Kutkat, O., El Sayes, M., GabAllah, M., AbdAllah, H., Gabre, R. M., AlKhazindar, M. M., Kandeil, A., McKenzie, P. P., Webby, R. J., Ali, M. A., Kayali, G., & El-Shesheny, R. (2025). Genetic Characterization and Pathogenesis of Highly Pathogenic Avian Influenza Virus A (H5N1) Isolated in Egypt During 2021–2023. Viruses, 17(10), 1370. https://doi.org/10.3390/v17101370

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop